Literature DB >> 33760988

Disease spectrum of gastric cancer susceptibility genes.

Sophia K McKinley1, Preeti Singh2, Kanhua Yin2,3, Jin Wang2,4, Jingan Zhou2,5, Yujia Bao6, Menghua Wu6, Kush Pathak7, John T Mullen2, Danielle Braun3,8, Kevin S Hughes9.   

Abstract

Pathogenic variants in germline cancer susceptibility genes can increase the risk of a large number of diseases. Our study aims to assess the disease spectrum of gastric cancer susceptibility genes and to develop a comprehensive resource of gene-disease associations for clinicians. Twenty-seven potential germline gastric cancer susceptibility genes were identified from three review articles and from six commonly used genetic information resources. The diseases associated with each gene were evaluated via a semi-structured review of six genetic resources and an additional literature review using a natural language processing (NLP)-based procedure. Out of 27 candidate genes, 13 were identified as gastric cancer susceptibility genes (APC, ATM, BMPR1A, CDH1, CHEK2, EPCAM, MLH1, MSH2, MSH6, MUTYH-Biallelic, PALB2, SMAD4, and STK11). A total of 145 gene-disease associations (with 45 unique diseases) were found to be associated with these 13 genes. Other gastrointestinal cancers were prominent among identified associations, with 11 of 13 gastric cancer susceptibility genes also associated with colorectal cancer, eight genes associated with pancreatic cancer, and seven genes associated with small intestine cancer. Gastric cancer susceptibility genes are frequently associated with other diseases as well as gastric cancer, with potential implications for how carriers of these genes are screened and managed. Unfortunately, commonly used genetic resources provide heterogeneous information with regard to these genes and their associated diseases, highlighting the importance of developing guides for clinicians that integrate data across available resources and the medical literature.

Entities:  

Keywords:  Cancer prevention; Cancer susceptibility gene; Disease spectrum; Gastric cancer; Germline

Year:  2021        PMID: 33760988     DOI: 10.1007/s12032-021-01495-w

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  2 in total

Review 1.  What's New in Genetic Testing for Cancer Susceptibility?

Authors:  Jennifer K Plichta; Molly Griffin; Joseph Thakuria; Kevin S Hughes
Journal:  Oncology (Williston Park)       Date:  2016-09-15       Impact factor: 2.990

2.  An atlas connecting shared genetic architecture of human diseases and molecular phenotypes provides insight into COVID-19 susceptibility.

Authors:  Liuyang Wang; Thomas J Balmat; Alejandro L Antonia; Florica J Constantine; Ricardo Henao; Thomas W Burke; Andy Ingham; Micah T McClain; Ephraim L Tsalik; Emily R Ko; Geoffrey S Ginsburg; Mark R DeLong; Xiling Shen; Christopher W Woods; Elizabeth R Hauser; Dennis C Ko
Journal:  medRxiv       Date:  2020-12-22
  2 in total
  3 in total

1.  Interleukin-8 Regulates the Autophagy and Apoptosis in Gastric Cancer Cells via Regulating PI3K/Akt Signaling Pathway.

Authors:  Liang Yu; Guoqiang Zhou; Zhiliang Shi; Jian Guo; Shengyuan Yu; Cheng Yu; Chenglong Shen
Journal:  Dis Markers       Date:  2022-08-11       Impact factor: 3.464

2.  Bioinformatics Analysis Based on TCGA: MUC16 Mutation Correlates with Clinical Outcome in Gastric Cancer.

Authors:  Liang Huang; Shuang Zheng; Junhui Fu; Meng Zhang; Xiaogang Ge; Ning Mu
Journal:  Dis Markers       Date:  2022-08-23       Impact factor: 3.464

3.  Proteogenomic analysis in an early onset diffuse gastric cancer patient revealed alterations in PIK3R1, TP53, SMAD4 and a potential role of the PI3K-AKT and EGFR pathways: a case report.

Authors:  Miguel Cordova-Delgado; Mauricio P Pinto; Gonzalo Pizarro; Elard Koch; Cristian Vargas; Mauricio Hernández; Guillermo Nourdin; Pablo Saldivia; Maria Paz Rodriguez Z; Alejandro Berkovits; Patricio Manque; Juvenal A Rios; Benjamin Garcia-Bloj; Marcelo Garrido
Journal:  J Gastrointest Oncol       Date:  2022-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.